# Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics

> **NCT01845194** · PHASE1 · COMPLETED · sponsor: **Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH** · enrollment: 117 (actual)

## Conditions studied

- Drug Biotransformation
- Membrane Transport

## Interventions

- **DRUG:** Codeine
- **DRUG:** Midazolam
- **DRUG:** Pravastatin
- **DRUG:** Torsemide
- **DRUG:** Talinolol
- **DRUG:** Caffeine
- **DRUG:** Metoprolol

## Key facts

- **NCT ID:** NCT01845194
- **Lead sponsor:** Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2014-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01845194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01845194, "Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01845194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*